Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 181

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Limb-Girdle Muscular Dystrophy in the United States

Moore, Steven A., Shilling, Christopher J., Westra, Steven, Wall, Cheryl, Wicklund, Matthew P., Stolle, Catherine, Brown, Charlotte A., Michele, Daniel E., Piccolo, Federica, Winder, Thomas L., Stence, Aaron, Barresi, Rita, King, Nick, King, Wendy, Florence, Julaine, Campbell, Kevin P., Fenichel, Gerald M., Stedman, Hansell H., Kissel, John T., Griggs, Robert C., Pandya, Shree, Mathews, Katherine D., Pestronk, Alan, Serrano, Carmen, Darvish, Daniel, Mendell, Jerry R. · 2006 · Journal of Neuropathology and Experimental Neurology

Abstract

Limb-girdle muscular dystrophy (LGMD) has been linked to 15 chromosomal loci, 7 autosomal-dominant (LGMD1A to E) and 10 autosomal-recessive (LGMD2A to J). To determine the distribution of subtypes among patients in the United States, 6 medical centers evaluated patients with a referral diagnosis of LGMD. Muscle biopsies provided histopathology and immunodiagnostic testing, and their protein abnormalities along with clinical parameters directed mutation screening. The diagnosis in 23 patients was a disorder other than LGMD. Of the remaining 289 unrelated patients, 266 had muscle biopsies sufficient for complete microscopic evaluation; 121 also underwent Western blotting. From this combined evaluation, the distribution of immunophenotypes is 12% calpainopathy, 18% dysferlinopathy, 15% sarcoglycanopathy, 15% dystroglycanopathy, and 1.5% caveolinopathy. Genotypes distributed among 2 dominant and 7 recessive subtypes have been determined for 83 patients. This study of a large racially and ethnically diverse population of patients with LGMD indicates that establishing a putative subtype is possible more than half the time using available diagnostic testing. An efficient approach to genotypic diagnosis is muscle biopsy immunophenotyping followed by directed mutational analysis. The most common LGMDs in the United States are calpainopathies, dysferlinopathies, sarcoglycanopathies, and dystroglycanopathies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/01.jnen.0000235854.77716.6c

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 181

Metadata

Authors
Moore, S. A., Shilling, C. J., Westra, S., Wall, C., Wicklund, M. P., Stolle, C., Brown, C. A., Michele, D. E., Piccolo, F., Winder, T. L., Stence, A., Barresi, R., King, N., King, W., Florence, J., Campbell, K. P., Fenichel, G. M., Stedman, H. H., Kissel, J. T., Griggs, R. C., Pandya, S., Mathews, K. D., Pestronk, A., Serrano, C., Darvish, D., & Mendell, J. R.
Venue
Journal of Neuropathology and Experimental Neurology
Published
2006-10
Volume
65
Issue
10
Pages
995-1003
ISSN
0022-3069 (ISSN-L)
OpenAlex
W1990956920
Cited by
181
References
2
FWCI
3.81
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Limb-Girdle Muscular Dystrophy in the United States. https://app.cochat.ai/papers/10.1097/01.jnen.0000235854.77716.6c
The paper
Moore, S. A., Shilling, C. J., Westra, S., Wall, C., Wicklund, M. P., Stolle, C., Brown, C. A., Michele, D. E., Piccolo, F., Winder, T. L., Stence, A., Barresi, R., King, N., King, W., Florence, J., Campbell, K. P., Fenichel, G. M., Stedman, H. H., Kissel, J. T., . . . Mendell, J. R. (2006). Limb-Girdle Muscular Dystrophy in the United States. Journal of Neuropathology and Experimental Neurology. https://doi.org/10.1097/01.jnen.0000235854.77716.6c

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.